Humana's investment focus and strategy are centered on advancing its core healthcare business rather than solely generating financial returns. The company invests directly in healthcare services, healthcare information technology, and insurance sectors, particularly in areas like primary care, home healthcare, and technology startups, to scale operations, upgrade technology, and integrate with Humana's vision for healthcare.
100% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is growth (43% of deals). Average disclosed round size is $132.0M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Growth
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Thyme Care | Series D | $97M | Sep 2025 |
 DispatchHealth | Growth | $259M | Nov 2022 |
 Aspen RxHealth | Series B | $23M | Jan 2021 |
 Heal | Growth | $100M | Jul 2020 |
| BBuoy Health | Series B | $15M | Aug 2019 |
 Iora Health | Series E | $100M | May 2018 |
| DispatchHealth | Growth | $330M | — |
Top Co-Investors
Optum Ventures3 shared
F-Prime Capital2 shared
Flare Capital Partners2 shared
Khosla Ventures1 shared
Temasek Holdings1 shared
.406 Ventures1 shared
Devonshire Investors1 shared
GE Ventures1 shared
Polaris Venture Partners1 shared
Bessemer Venture Partners1 shared
Takeda1 shared
McKesson Ventures1 shared
Adams Street1 shared
Blue Shield of California1 shared
Oak HC/FT1 shared
CVS Health1 shared
Foresite Capital1 shared
a16z Bio + Health1 shared
Concord Health Partners1 shared
AlleyCorp1 shared
Last updated: 16 April 2026